Agios Pharmaceuticals Inc (STU:8AP)
€ 45.8 0.8 (1.78%) Market Cap: 2.49 Bil Enterprise Value: 1.59 Bil PE Ratio: 4.05 PB Ratio: 1.61 GF Score: 28/100

Agios Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 02, 2020 / 07:00PM GMT
Release Date Price: €38.11 (-2.03%)
Tyler Martin Van Buren
Piper Sandler & Co., Research Division - Principal & and Senior Biotech Analyst

Great. Good afternoon, everyone. My name is Tyler Van Buren. I'm the senior biotech analyst at Piper Sandler. Welcome to Piper's 32nd Annual Healthcare Conference. As this is our first time with a virtual format, we appreciate you all logging in.

And for this session, it is my sincere pleasure to have Agios here with us. And from Agios, we have Jackie Fouse, the Chief Executive Officer. Jackie, thanks very much for being here with us.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Hi, everybody. Thanks for having us, Tyler.

Questions & Answers

Tyler Martin Van Buren
Piper Sandler & Co., Research Division - Principal & and Senior Biotech Analyst

(Operator Instructions) But maybe we could go ahead and get started with a general question. Jackie, you're wrapping up your second year as CEO, and you continue to refine the business and the pipeline. So maybe you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot